Infographic
Cell and gene therapy (C>) products offer groundbreaking treatment options for conditions once considered untreatable. However, their specialized manufacturing processes pose complex challenges for extractables and leachables (E&L) testing. Single-use fluoropolymer components used during production may contain PFAS (“forever chemicals”) which can leach into the final product. This resource outlines a regulatory-endorsed framework for conducting E&L testing in C>, grounded in real-world case studies and FDA-reviewed data. Download now to explore the role of PFAS in C> processing, key E&L testing challenges, practical testing parameters, and more.
Offered Free by: Element
See All Resources from: Element
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.